Ozempic weight-loss drug gaining popularity despite side effects
The Conversation — April 1, 2024, 08:00 PM UTC
Summary: The rise of weight-loss drugs like Ozempic has led to over nine million prescriptions in the US in the last three months of 2022. Studies show significant weight loss with semaglutide, with participants losing up to 14.9% of body weight. Benefits include reduced chronic disease risk factors and improved quality of life. Side effects include gastrointestinal symptoms and fatigue, with some severe cases reported. Access to Ozempic may be challenging due to shortages.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.